Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H12Cl2N2 |
| Molecular Weight | 231.122 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=CC(N2CCNCC2)=C1Cl
InChI
InChIKey=UDQMXYJSNNCRAS-UHFFFAOYSA-N
InChI=1S/C10H12Cl2N2/c11-8-2-1-3-9(10(8)12)14-6-4-13-5-7-14/h1-3,13H,4-7H2
| Molecular Formula | C10H12Cl2N2 |
| Molecular Weight | 231.122 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL217 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24827597 |
1160.0 nM [Ki] | ||
Target ID: CHEMBL234 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22632094 |
197.4 nM [Ki] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and in vitro antimicrobial study of Schiff base and thiazolidinone of 1-cyclopropyl-6-fluoro-7-[4-(2,3-dichlorophenyl)piperazin-1-yl]-4-quinolone. | 2010-03-10 |
|
| First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure. | 2005-12-15 |
|
| Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands. | 2005-01-03 |
|
| N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists. | 2003-07-07 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:40:13 GMT 2025
by
admin
on
Mon Mar 31 21:40:13 GMT 2025
|
| Record UNII |
891W3EV0B1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
41202-77-1
Created by
admin on Mon Mar 31 21:40:13 GMT 2025 , Edited by admin on Mon Mar 31 21:40:13 GMT 2025
|
PRIMARY | |||
|
2,3-DICHLOROPHENYLPIPERAZINE
Created by
admin on Mon Mar 31 21:40:13 GMT 2025 , Edited by admin on Mon Mar 31 21:40:13 GMT 2025
|
PRIMARY | |||
|
891W3EV0B1
Created by
admin on Mon Mar 31 21:40:13 GMT 2025 , Edited by admin on Mon Mar 31 21:40:13 GMT 2025
|
PRIMARY | |||
|
75375
Created by
admin on Mon Mar 31 21:40:13 GMT 2025 , Edited by admin on Mon Mar 31 21:40:13 GMT 2025
|
PRIMARY | |||
|
851833
Created by
admin on Mon Mar 31 21:40:13 GMT 2025 , Edited by admin on Mon Mar 31 21:40:13 GMT 2025
|
PRIMARY | |||
|
DTXSID90961499
Created by
admin on Mon Mar 31 21:40:13 GMT 2025 , Edited by admin on Mon Mar 31 21:40:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
N-Dealkylation metabolite thru CYP3A4 exposure
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|